article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp

NORML

” A separate study published in 2017 reported that U-Miss samples contain far lower levels of both THC and CBD than do commercially available cannabis. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.

Hemp 197
article thumbnail

Medical Marijuana Offers Hope for Treatment of PTSD

FloridaMarijuana.net

According to a 2017 report published by the National Academies of Sciences , PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The stress that results from traumatic events precipitates a spectrum of psycho-emotional and physiopathological outcomes.

Treatment 182
article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

The joint study conducted by Ben Gurion University and Soroka Medical Center in Beersheba analyzed 188 teens diagnosed with Autistic Spectrum Disorder (ASD) between 2015 and 2017. 2017) The current status of artisanal cannabis for the treatment of epilepsy in the United States. tetrahydrocannabinol (THC). improvement in good sleep.

article thumbnail

Cann Group (ASX:CAN) and Emyria (ASX:EMD) scrap CBD deal for other opportunities

Cannabis Law Report

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017.

CBD 105
article thumbnail

Yes! You can Get a Medical Marijuana Card for Anxiety in Florida

FloridaMarijuana.net

The research Men’s Journal is referring to is the 2017 journal article published in Clinical Psychology Review titled: Medical cannabis and mental health : A guided systematic review. The authors conclude that: Mental health conditions are prominent among the reasons for medical cannabis use.

Marijuana 145